LUZ ANAYA: Open Payments
NPI 1366209785 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 21 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $367 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $123 |
| Corcept Therapeutics | 3 | $58 |
| Amgen Inc. | 3 | $54 |
| Novo Nordisk Inc | 3 | $49 |
| Xeris Pharmaceuticals, Inc. | 2 | $33 |
| Vifor Pharma, Inc. | 2 | $32 |
| Abbott Laboratories | 1 | $26 |
| Exact Sciences Corporation | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
Products named: REZDIFFRA, Korlym, Ozempic, OTEZLA, RECORLEV, Veltassa, FREESTYLE LIBRE 3, The Cologuard Plus Collection Kit.
Industry payments across NJ — which companies pay providers there.
